The pan-European STOXX 600 index closed up nearly 1%, with Novo Nordisk rising over 4%
Market expectations for a rate cut by the Federal Reserve in December have resurfaced, with European stocks closing slightly higher on Monday, as the pan-European STOXX 600 index rose by 0.9%.
Danish pharmaceutical company Novo Nordisk announced positive results from the mid-term trials of its new generation weight loss drug Amycretin, with its stock price rising over 4%.
The UK FTSE 100 index closed up 74 points or 0.8%, at 9,609 points. The German DAX index closed up 225 points or 1%, at 23,464 points. The French CAC40 index closed up 66 points or 0.8%, at 8,025 points
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments